SERA(Sera Prognostics, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $82.00K | $268.00K | $306.00K | $77.00K | $81.00K |
| 毛利润 | — | — | $96.00K | −$5.00K | −$83.00K |
| 营业利润 | −$35.40M | −$45.65M | −$39.82M | −$36.63M | −$36.50M |
| 净利润 | −$35.01M | −$44.19M | −$36.24M | −$32.90M | −$31.93M |
| 经营现金流 | −$31.64M | −$34.61M | −$27.19M | −$14.19M | −$25.62M |
| 自由现金流 | −$32.94M | −$35.40M | −$27.32M | −$14.24M | −$26.35M |
| 摊薄每股收益 | $-2.33 | $-1.43 | $-1.16 | $-0.99 | $-0.67 |